Results 151 to 160 of about 1,997 (174)

Durable lipid-lowering beyond 10 years with lomitapide in homozygous familial hypercholesterolemia: A real-world experience in Taiwan.

Journal of Clinical Lipidology
BACKGROUND Homozygous familial hypercholesterolemia (HoFH) is a rare, life-threatening disorder characterized by extremely elevated low-density lipoprotein cholesterol (LDL-C) and premature atherosclerotic cardiovascular disease (ASCVD). OBJECTIVE This
Chao-Feng Lin, Wen-Hwa Wang, M. Charng
semanticscholar   +1 more source

Targeting PP2A with lomitapide suppresses colorectal tumorigenesis through the activation of AMPK/Beclin1-mediated autophagy

Cancer Letters, 2021
Qing-Yu He, Wen-Wen Xu, Qian Zuo
exaly  

Lomitapide for the treatment of pediatric homozygous familial hypercholesterolemia

Expert Opinion on Pharmacotherapy
A. Hooper, Damon A. Bell, J. R. Burnett
semanticscholar   +1 more source

Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study

European Journal of Preventive Cardiology, 2022
Jeanine E Roeters van Lennep, Alessia di Costanzo, Giovanni B Vigna   +2 more
exaly  

Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

Circulation, 2017
Marina Cuchel, Giovanni B Vigna, Daniel Gaudet   +2 more
exaly  

Pharmacokinetic Interactions of the Microsomal Triglyceride Transfer Protein Inhibitor, Lomitapide, with Drugs Commonly Used in the Management of Hypercholesterolemia

Pharmacotherapy, 2014
Marina Cuchel, Sony Tuteja, Danielle Duffy   +2 more
exaly  

Case report: The efficacy and safety of lomitapide in a homozygous familial hypercholesterolemic child

Journal of Clinical Lipidology, 2019
Raul D Santos
exaly  

Ezetimibe/lomitapide/rosuvastatin

Reactions weekly

semanticscholar   +1 more source

Lomitapide and Mipomersen—Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis

Current Atherosclerosis Reports, 2019
Adrian D Marais, Frederick J Raal, Raul D Santos   +2 more
exaly  

† Real-world safety and effectiveness of lomitapide in homozygous familial hypercholesterolemia over 10 years: Data from LOWER

Journal of Clinical Lipidology
J. Underberg, Christopher Cannon, Dominique Larrey, Lukas Makris, Inbar Aviezer, Ruth Louzado, S. Löwe, Sallyann O'Brien, Dirk Blom   +8 more
semanticscholar   +1 more source